Mieke Ten eikelder

Dr. Mieke Ten eikelder


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in The Lancet
Verified
Journal Article
Closed access
MEMieke Ten eikelder
Mieke Ten eikelder
KRKatrien Oude Rengerink
Katrien Oude Rengerink
MJMarta Jozwiak
Marta Jozwiak
JLJan W de Leeuw
Jan W de Leeuw
IGIrene M de Graaf
Irene M de Graaf
KBKitty W M Bloemenkamp
Kitty W M Bloemenkamp

25 April 2017 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
MEMieke Ten eikelder
Mieke Ten eikelder
GBG‐J van Baaren
G‐J van Baaren
KRK Oude Rengerink
K Oude Rengerink
MJM Jozwiak
M Jozwiak
JLJw de Leeuw
Jw de Leeuw
BMBw Mol
Bw Mol

19 March 2013 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
MEMieke Ten eikelder
Mieke Ten eikelder
FNFemke Neervoort
Femke Neervoort
KRKatrien Oude Rengerink
Katrien Oude Rengerink
MJMarta Jozwiak
Marta Jozwiak
JLJan-Willem de Leeuw
Jan-Willem de Leeuw
KBKitty W M Bloemenkamp
Kitty W M Bloemenkamp
Background: Induction of labour is a common obstetric procedure. At present, different methods are used for induction of labour in women with an unfavourable cervix. Recently, we showed that in term women with an unfavorable cervix the use of a Foley catheter in comparison with vaginal Prostaglandin E2 gel, results in a comparable vaginal delivery rate. A meta-analysis on the subject indicated lower rates of hyperstimulation, and probably as a sequel fewer cases of postpartum haemorrhage. Misoprostol (PgE1) is another type of prostaglandin frequently used for labour induction, recommended by the international federation of gynaecology and obstetrics (FIGO). Misoprostol can be administered by vaginal, rectal and oral route. There is evidence that oral administration results in less asphyxia and hyperstimulation than vaginal administration. At present, valid comparisons between oral misoprostol and Foley catheter are lacking. Therefore, we propose a randomised controlled trial comparing Foley catheter to oral misoprostol in order to assess safety and cost-effectiveness. Methods/Design: We plan a multicentre, randomised, controlled, open-label clinical trial among term pregnant women with a vital singleton in cephalic presentation, unfavorable cervix, intact membranes and an indication for induction of labour. After informed consent, women will be randomly allocated by a webbased randomisation system to transcervical Foley catheter or oral misoprostol (50 mcg every 4 hours). The primary outcome will be a composite of complications of uterine hyperstimulation, i.e. post partum haemorrhage and asphyxia. Secondary outcomes are mode of delivery, maternal and neonatal morbidity, costs and women’s preference. Serious adverse events such as severe maternal or neonatal morbitity or mortality will be monitored and reported to an independent data safety monitory board. With a sample size of 1860 women we will be able to demonstrate a 5% non-inferiority of the Foley catheter as compared to misoprostol for the composite outcome. Discussion: Worldwide, various methods are being used for labour induction. Results of the proposed trial will contribute to the answer which method of induction of labour is most safe, cost-effective, and patient friendly and will help to construct evidence based guidelines. Trial registration: The Netherlands Trial Register NTR3466

Verified
Journal Article
Open access
PDF file
VDValentina Discepolo
Valentina Discepolo
GLGiuliana Lania
Giuliana Lania
MEMieke Ten eikelder
Mieke Ten eikelder
MNMERLIN NANAYAKKARA
MERLIN NANAYAKKARA
LSLeandra Sepe
Leandra Sepe
Maria Vittoria BaroneMaria Vittoria Barone
Maria Vittoria Barone
Celiac disease (CD) is a frequent intestinal inflammatory disease occurring in genetically susceptible individuals upon gluten ingestion. Recent studies point to a role in CD for genes involved in cell shape, adhesion and actin rearrangements, including a Rho family regulator, Rho GTPase-activating protein 31 (ARHGAP31). In this study, we investigated the morphology and actin cytoskeletons of peripheral monocyte-derived dendritic cells (DCs) from children with CD and controls when in contact with a physiological substrate, fibronectin. DCs were generated from peripheral blood monocytes of pediatric CD patients and controls. After adhesion on fibronectin, DCs showed a higher number of protrusions and a more elongated shape in CD patients compared with controls, as assessed by immunofluorescence actin staining, transmitted light staining and video time-lapse microscopy. These alterations did not depend on active intestinal inflammation associated with gluten consumption and were specific to CD, since they were not found in subjects affected by other intestinal inflammatory conditions. The elongated morphology was not a result of differences in DC activation or maturation status, and did not depend on the human leukocyte antigen (HLA)-DQ2 haplotype. Notably, we found that ARH-GAP31 mRNA levels were decreased while RhoA-GTP activity was increased in CD DCs, pointing to an impairment of the Rho pathway in CD cells. Accordingly, Rho inhibition was able to prevent the cytoskeleton rearrangements leading to the elongated morphology of celiac DCs upon adhesion on fibronectin, confirming the role of this pathway in the observed phenotype. In conclusion, adhesion on fibronectin discriminated CD from the controls’ DCs, revealing a gluten-independent CD-specific cellular phenotype related to DC shape and regulated by RhoA activity.

1 January 2014 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
MEMieke Ten eikelder
Mieke Ten eikelder
BMBen Willem J. Mol
Ben Willem J. Mol
KBKitty Bloemenkamp
Kitty Bloemenkamp

1 March 2017 in Obstetric Anesthesia Digest
Verified
Journal Article
Closed access
PDF file
MEMieke Ten eikelder
Mieke Ten eikelder
KRKatrien O. Rengerink
Katrien O. Rengerink
MJMarta Jozwiak
Marta Jozwiak
JLJan W. de Leeuw
Jan W. de Leeuw
IGIrene M. de Graaf
Irene M. de Graaf
KBKitty W.M. Bloemenkamp
Kitty W.M. Bloemenkamp
(Lancet. 2016;387:1619–1628) When conditions pose a threat to mother or baby, obstetric interventions, including induction of labor, are required.